Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.74B | 26.69B | 24.22B | 18.54B | 13.57B | 7.34B |
Gross Profit | 8.22B | 9.53B | 7.46B | 5.78B | 4.17B | 3.02B |
EBITDA | 2.58B | 3.84B | 2.51B | 2.03B | 1.57B | 1.26B |
Net Income | 993.53M | 1.70B | 1.39B | 1.15B | 892.41M | 667.02M |
Balance Sheet | ||||||
Total Assets | 33.22B | 30.47B | 24.02B | 21.96B | 23.02B | 12.34B |
Cash, Cash Equivalents and Short-Term Investments | 6.37B | 7.67B | 4.66B | 5.23B | 3.65B | 3.47B |
Total Debt | 16.97B | 12.13B | 8.42B | 8.67B | 11.64B | 3.19B |
Total Liabilities | 19.98B | 16.12B | 11.56B | 10.64B | 13.22B | 4.46B |
Stockholders Equity | 12.72B | 13.78B | 12.27B | 11.09B | 9.80B | 7.88B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 185.31M | 73.83M | 3.78B | -8.16B | -3.82B |
Operating Cash Flow | 0.00 | 435.30M | 452.64M | 4.36B | -7.31B | -3.57B |
Investing Cash Flow | 0.00 | -1.37B | -376.36M | -427.07M | -1.64B | -253.80M |
Financing Cash Flow | 0.00 | 1.94B | -554.26M | -3.13B | 9.31B | 3.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥46.01B | 5.23 | 2.50% | 14.08% | 46.84% | ||
75 Outperform | ¥51.81B | 12.49 | 3.71% | 57.21% | 16.38% | ||
72 Outperform | ¥38.86B | 6.00 | 4.04% | 11.98% | 0.42% | ||
71 Outperform | ¥47.15B | 7.84 | 5.30% | 29.46% | 32.52% | ||
70 Outperform | ¥51.38B | 34.35 | 0.29% | 28.02% | 37.68% | ||
64 Neutral | $6.92B | 18.66 | -1.93% | 6.85% | 4.65% | -25.39% | |
62 Neutral | ¥50.73B | 29.63 | 0.48% | 10.21% | 22.88% |
SRE Holdings Corporation announced the issuance of 14,850 new shares as restricted stock compensation, aimed at aligning the interests of directors, executive officers, and employees with shareholders by sharing the benefits and risks of stock price fluctuations. This strategic move is expected to motivate key personnel to contribute to the company’s growth and enhance corporate value, potentially strengthening its position in the market.
SRE Holdings Corporation announced its relationship with Sony Group Corporation, which holds a 23.30% voting stake in SRE, classifying it as an ‘Other Affiliated Company.’ Despite this affiliation, SRE maintains operational independence, with no significant financial impact from royalties paid to Sony for AI technology use. The company ensures its independence through regulatory oversight and distinct business operations, avoiding competitive overlap with Sony.
SRE Holdings Corporation reported a significant increase in its consolidated financial results for the fiscal year ended March 31, 2025, with net sales rising by 10.2% and operating profit increasing by 40.5%. The company also announced a dividend payment of 15 yen per share, reflecting a positive outlook for stakeholders. The inclusion of MEDIX Co, Ltd. into its consolidation scope and changes in accounting policies have been noted, indicating strategic expansion and adaptation to new standards.